Filling the need for trusted information on national health issues…

Experimental Malaria Vaccine Candidate Uses New Target To Stop Parasite’s Growth

News outlets report on a new experimental malaria vaccine candidate.

Deustche Welle: U.S. researchers say a new malaria vaccine candidate stops the parasite mid life cycle
“Most malaria vaccine candidates work by preventing parasites from entering human red blood cells. A newly discovered antibody takes a different approach: it traps the parasites inside the cells…” (Osterath, 5/22).

NPR: Experimental Malaria Vaccine Blocks The Bad Guy’s Exit
“For the first time in decades, researchers trying to develop a vaccine for malaria have discovered a new target they can use to attack this deadly and common parasite…” (Harris, 5/22).

Science: New Malaria Vaccine Shows Promise in Mice
“…[A] study of malaria-resistant children in Tanzania has turned up an antibody that helps stop the infection in its tracks. Based on this antibody’s actions, scientists have developed a preliminary vaccine that shows promise in mice…” (Norton, 5/22).

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.